rRelapse/refractory AML (day+647); primary refractory T lymphoblastic leukemia in remission with MRD+ after salvage chemotherapy (day +469); Untreated MDS with TP53 mutation(day+723); FLT3-ITD + AML in remission with MRD+(day+622). Here, TP53 is linked to myelodysplastic syndrome.